In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Givaudan Invests In Creative Center, Reports “Strong Start” To 2007

This article was originally published in The Rose Sheet

Executive Summary

This spring, Givaudan will begin construction on "the most modern and technologically advanced commercial and perfume creation center in the industry," the company states April 2

You may also be interested in...



Givaudan Consumer Products, Specialty Ingredients Drive 2007 Results

Givaudan's fragrance business grew 3.9 percent on a pro forma basis to $1.75 billion in fiscal 2007 owing to the "excellent performance" of its consumer products division in all regions and strong sales of specialty ingredients, the firm reports Feb. 19

Givaudan Consumer Products, Specialty Ingredients Drive 2007 Results

Givaudan's fragrance business grew 3.9 percent on a pro forma basis to $1.75 billion in fiscal 2007 owing to the "excellent performance" of its consumer products division in all regions and strong sales of specialty ingredients, the firm reports Feb. 19

Givaudan Predicts Quest Buy Will Prompt Rivals To Move Up In Weight Class

Givaudan expects its March 2 acquisition of Quest International - which the fragrance and flavor developer claims will make it 60 percent larger than its closest competitor - to compel similar movement throughout the industry

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014636

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel